Methods for identifying modulators of apoptosis
    2.
    发明授权
    Methods for identifying modulators of apoptosis 失效
    识别凋亡调节剂的方法

    公开(公告)号:US07927816B2

    公开(公告)日:2011-04-19

    申请号:US12206670

    申请日:2008-09-08

    申请人: John C. Reed Bin Guo

    发明人: John C. Reed Bin Guo

    IPC分类号: G01N33/53 A61K38/00 C07K14/00

    摘要: The invention provides a method of identifying an effective compound that modulates the binding of Humanin to Bax or Bid. The invention also provides a method of identifying an effective compound that modulates an activity of Bax or Bid. In addition, the invention provides a method of identifying a Humanin-like compound that binds to Bax or Bid or modulates an activity of Bax or Bid, or inhibits the apoptotic activity of Bax or Bid. The invention further provides an isolated polypeptide containing a mitochondrial-derived form of Humanin (SEQ ID NO:3) or a functional fragment thereof where the fragment contains the methionine at position 16 of SEQ ID NO:3.

    摘要翻译: 本发明提供了鉴定调节人源蛋白与Bax或Bid的结合的有效化合物的方法。 本发明还提供了鉴定调节Bax或Bid的活性的有效化合物的方法。 此外,本发明提供了鉴定结合Bax或Bid或调节Bax或Bid的活性或抑制Bax或Bid的凋亡活性的人类素样化合物的方法。 本发明还提供了含有线粒体衍生形式的人源(SEQ ID NO:3)或其功能片段的分离的多肽,其中该片段含有SEQ ID NO:3的16位的甲硫氨酸。

    Bcl-G polypeptides, encoding nucleic acids and methods of use
    3.
    发明授权
    Bcl-G polypeptides, encoding nucleic acids and methods of use 失效
    Bcl-G多肽,编码核酸和使用方法

    公开(公告)号:US07638324B2

    公开(公告)日:2009-12-29

    申请号:US09738396

    申请日:2000-12-14

    摘要: The invention provides Bcl-G polypeptides and encoding nucleic acids. Bcl-G polypeptides include Bcl-GL and Bcl-GS. The invention also provides mouse Bcl-G. The invention also provides vectors containing Bcl-G nucleic acids, host cells containing such vectors, Bcl-G anti-sense nucleic acids and related compositions. The invention additionally provides Bcl-G oligonucleotides that can be used to hybridize to or amplify a Bcl-G nucleic acid. Anti-Bcl-G specific antibodies are also provided. Further provided are kits containing Bcl-G nucleic acids or Bcl-G specific antibodies. Such kits and reagents can be used to diagnose cancer, monitor response to therapy, or predict the prognosis of a cancer patient. The invention additionally provides methods of modulating apoptosis using Bcl-G polypeptides, encoding nucleic acids, or compounds that modulate the activity or expression of Bcl-G polypeptides. The methods for modulating apoptosis can be used to treat diseases such as cancer.

    摘要翻译: 本发明提供了Bcl-G多肽和编码核酸。 Bcl-G多肽包括Bcl-GL和Bcl-GS。 本发明还提供了小鼠Bcl-G。 本发明还提供含有Bcl-G核酸的载体,含有这些载体的宿主细胞,Bcl-G反义核酸和相关组合物。 本发明另外提供可用于与Bcl-G核酸杂交或扩增的Bcl-G寡核苷酸。 还提供抗Bcl-G特异性抗体。 还提供了含有Bcl-G核酸或Bcl-G特异性抗体的试剂盒。 这样的试剂盒和试剂可用于诊断癌症,监测对治疗的反应或预测癌症患者的预后。 本发明另外提供了使用调节Bcl-G多肽的活性或表达的Bcl-G多肽,编码核酸或化合物来调节凋亡的方法。 调节凋亡的方法可用于治疗癌症等疾病。

    METHODS FOR IDENTIFYING MODULATORS OF APOPTOSIS
    5.
    发明申请
    METHODS FOR IDENTIFYING MODULATORS OF APOPTOSIS 审中-公开
    识别疫苗调节剂的方法

    公开(公告)号:US20110230364A1

    公开(公告)日:2011-09-22

    申请号:US13053169

    申请日:2011-03-21

    申请人: John C. Reed Bin Guo

    发明人: John C. Reed Bin Guo

    IPC分类号: C40B30/04

    摘要: The invention provides a method of identifying an effective compound that modulates the binding of Humanin to Bax or Bid. The invention also provides a method of identifying an effective compound that modulates an activity of Bax or Bid. In addition, the invention provides a method of identifying a Humanin-like compound that binds to Bax or Bid or modulates an activity of Bax or Bid, or inhibits the apoptotic activity of Bax or Bid. The invention further provides an isolated polypeptide containing a mitochondrial-derived form of Humanin (SEQ ID NO:3) or a functional fragment thereof where the fragment contains the methionine at position 16 of SEQ ID NO:3.

    摘要翻译: 本发明提供了鉴定调节人源蛋白与Bax或Bid的结合的有效化合物的方法。 本发明还提供了鉴定调节Bax或Bid的活性的有效化合物的方法。 此外,本发明提供了鉴定结合Bax或Bid或调节Bax或Bid的活性或抑制Bax或Bid的凋亡活性的人类素样化合物的方法。 本发明还提供了含有线粒体衍生形式的人源(SEQ ID NO:3)或其功能片段的分离的多肽,其中该片段含有SEQ ID NO:3的16位的甲硫氨酸。

    METHODS FOR IDENTIFYING MODULATORS OF APOPTOSIS
    7.
    发明申请
    METHODS FOR IDENTIFYING MODULATORS OF APOPTOSIS 失效
    识别疫苗调节剂的方法

    公开(公告)号:US20090075292A1

    公开(公告)日:2009-03-19

    申请号:US12206670

    申请日:2008-09-08

    申请人: John C. Reed Bin Guo

    发明人: John C. Reed Bin Guo

    IPC分类号: G01N33/53

    摘要: The invention provides a method of identifying an effective compound that modulates the binding of Humanin to Bax or Bid. The invention also provides a method of identifying an effective compound that modulates an activity of Bax or Bid. In addition, the invention provides a method of identifying a Humanin-like compound that binds to Bax or Bid or modulates an activity of Bax or Bid, or inhibits the apoptotic activity of Bax or Bid. The invention further provides an isolated polypeptide containing a mitochondrial-derived form of Humanin (SEQ ID NO:3) or a functional fragment thereof where the fragment contains the methionine at position 16 of SEQ ID NO:3.

    摘要翻译: 本发明提供了鉴定调节人源蛋白与Bax或Bid的结合的有效化合物的方法。 本发明还提供了鉴定调节Bax或Bid的活性的有效化合物的方法。 此外,本发明提供了鉴定结合Bax或Bid或调节Bax或Bid的活性或抑制Bax或Bid的凋亡活性的人类素样化合物的方法。 本发明还提供了含有线粒体衍生形式的人源(SEQ ID NO:3)或其功能片段的分离的多肽,其中该片段含有SEQ ID NO:3的16位的甲硫氨酸。

    Naphthalene-based inhibitors of anti-apoptotic proteins
    10.
    发明授权
    Naphthalene-based inhibitors of anti-apoptotic proteins 有权
    基于萘的抗凋亡蛋白抑制剂

    公开(公告)号:US09115061B2

    公开(公告)日:2015-08-25

    申请号:US12253918

    申请日:2008-10-17

    摘要: Methods of using apogossypol and its derivatives for treating inflammation is disclosed. Also, there is described a group of compounds having structure A, or a pharmaceutically acceptable salt, hydrate, N-oxide, or solvate thereof are provided: wherein each R is independently selected from the group consisting of H, C(O)X, C(O)NHX, NH(CO)X, SO2NHX, and NHSO2X, wherein X is selected from the group consisting of an alkyl, a substituted alkyl, an aryl, a substituted aryl, an alkylaryl, and a heterocycle. Compounds of group A may be used for treating various diseases or disorders, such as cancer.

    摘要翻译: 公开了使用果糖酚及其衍生物治疗炎症的方法。 此外,提供了一组具有结构A的化合物或其药学上可接受的盐,水合物,N-氧化物或溶剂合物:其中每个R独立地选自H,C(O)X, C(O)NHX,NH(CO)X,SO2NHX和NHSO2X,其中X选自烷基,取代的烷基,芳基,取代的芳基,烷基芳基和杂环。 A组的化合物可用于治疗各种疾病或病症,例如癌症。